| Literature DB >> 34334834 |
Zhuoran Ma1, Feifei Wang1, Yeteng Zhong1, Felix Salazar2, Jiachen Li1, Mingxi Zhang3, Fuqiang Ren1, Anna M Wu2, Hongjie Dai1.
Abstract
Most NIR-IIb fluorophores are nanoparticle-based probes with long retention ( ≈ 1 month or longer) in the body. Here, we applied a novel cross-linked coating to functionalize core/shell lead sulfide/cadmium sulfide quantum dots (PbS/CdS QDs) emitting at ≈ 1600 nm. The coating was comprised of an amphiphilic polymer followed by three crosslinked amphiphilic polymeric layers (P3 coating), imparting high biocompatibility and > 90% excretion of QDs within 2 weeks of intravenous administration. The P3-QDs were conjugated to an engineered anti-CD8 diabody (Cys-diabody) for in vivo molecular imaging of CD8 + cytotoxic T lymphocytes (CTLs) in response to anti-PD-L1 therapy. Two-plex molecular imaging in combination with down-conversion Er nanoparticles (ErNPs) was performed for real-time in vivo monitoring of PD-L1 positive tumor cells and CTLs with cellular resolution by non-invasive NIR-IIb light sheet microscopy. Imaging of angiogenesis in the tumor microenvironment and of lymph nodes deep in the body with a signal-to-background ratio of up to ≈ 170 was also achieved using P3-QDs.Entities:
Keywords: excretion; imaging agents; nanomedicine; nanoparticles; second near-infrared window
Year: 2020 PMID: 34334834 PMCID: PMC8324002 DOI: 10.1002/ange.202008083
Source DB: PubMed Journal: Angew Chem Weinheim Bergstr Ger ISSN: 0044-8249